Powell Fred M
Insider CIK 1331339 · ATRS Senior Vice President & CFO · NONE Vice President and CFO · LVTX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LVTX LAVA Therapeutics NV | D To issuer deriv | 2025-11-13 | 2025-11-17 | 124,700 | — | $0 | 0 | SEC↗ |
| LVTX LAVA Therapeutics NV | D To issuer | 2025-11-13 | 2025-11-17 | 65,000 | — | $0 | 0 | SEC↗ |
| LVTX LAVA Therapeutics NV | A Award deriv | 2025-02-13 | 2025-02-18 | 124,700 | — | $0 | 124,700 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 163,963 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 254,165 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 181,575 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 177,453 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 217,725 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 150,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 124,234 | $5.60 | $695.7K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 204,022 | $5.60 | $1.14M | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 587,014 | $5.60 | $3.29M | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2022-03-03 | 2022-03-04 | 27,780 | — | $0 | 802,542 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2022-03-03 | 2022-03-04 | 11,506 | $3.80 | $43.7K | 791,036 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2022-02-16 | 2022-02-18 | 11,496 | $3.66 | $42.1K | 774,762 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2022-02-16 | 2022-02-18 | 24,606 | — | $0 | 786,258 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-06-13 | 2021-06-14 | 11,880 | $4.45 | $52.9K | 761,652 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-06-13 | 2021-06-14 | 17,327 | $4.45 | $77.1K | 773,532 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 163,963 | — | $0 | 163,963 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 85,973 | $4.42 | $380.0K | 790,859 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-06-08 | 2021-06-10 | 12,045 | $4.39 | $52.9K | 704,886 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-03-01 | 2021-03-03 | 45,829 | — | $0 | 736,830 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-03-01 | 2021-03-03 | 19,899 | $4.50 | $89.5K | 716,931 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-02-17 | 2021-02-19 | 35,829 | $4.73 | $169.5K | 691,001 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-02-17 | 2021-02-19 | 80,365 | — | $0 | 726,830 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2020-11-12 | 2020-11-16 | 16,400 | $2.85 | $46.7K | 646,465 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-06-13 | 2020-06-15 | 8,564 | $2.78 | $23.8K | 630,065 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 254,165 | — | $0 | 254,165 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-06-11 | 2020-06-15 | 131,868 | $2.73 | $360.0K | 638,629 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-06-08 | 2020-06-09 | 8,683 | $3.13 | $27.2K | 506,761 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-06-07 | 2020-06-09 | 9,609 | $3.12 | $30.0K | 515,444 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-02-19 | 2020-02-21 | 63,234 | — | $0 | 548,844 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-02-19 | 2020-02-21 | 23,791 | $3.53 | $84.0K | 525,053 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 181,575 | — | $0 | 181,575 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 90,411 | $2.92 | $264.0K | 485,610 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-06-08 | 2019-06-11 | 8,684 | $2.81 | $24.4K | 395,199 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-06-07 | 2019-06-11 | 9,609 | $2.81 | $27.0K | 403,883 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 177,453 | — | $0 | 177,453 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2018-06-08 | 2018-06-11 | 91,667 | $2.70 | $247.5K | 413,492 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2018-06-07 | 2018-06-11 | 9,609 | $2.70 | $25.9K | 321,825 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2017-06-09 | 2017-06-13 | 130,000 | $2.79 | $362.7K | 331,434 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 217,725 | — | $0 | 217,725 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2017-06-07 | 2017-06-09 | 101,434 | $2.66 | $269.8K | 201,434 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2016-12-09 | 2016-12-12 | 100,000 | $2.03 | $203.0K | 100,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-10-31 | 2016-11-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-12 | 2016-07-12 | 137,500 | $28.93 | $3.98M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-12 | 2016-07-12 | 55,000 | $27.46 | $1.51M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-12 | 2016-07-12 | 50,000 | $27.03 | $1.35M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer | 2016-07-12 | 2016-07-12 | 156,064 | $30.25 | $4.72M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise deriv | 2016-07-06 | 2016-07-07 | 71,887 | — | $0 | 181,113 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-06 | 2016-07-12 | 181,113 | $27.13 | $4.91M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise | 2016-07-06 | 2016-07-07 | 71,887 | $3.12 | $224.3K | 156,064 | SEC↗ |
| CPXX Celator Pharmaceuticals In | G Gift | 2016-06-29 | 2016-07-01 | 1,665 | — | $0 | 84,177 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise deriv | 2016-06-23 | 2016-06-27 | 56,875 | — | $0 | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | F Tax w/h | 2016-06-23 | 2016-06-27 | 2,491 | $30.15 | $75.1K | 85,842 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise | 2016-06-23 | 2016-06-27 | 56,875 | $1.32 | $75.1K | 88,333 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award deriv | 2016-01-27 | 2016-01-29 | 137,500 | — | $0 | 137,500 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award deriv | 2016-01-27 | 2016-01-29 | 56,875 | — | $0 | 56,875 | SEC↗ |
| CPXX Celator Pharmaceuticals In | P Buy | 2015-10-05 | 2015-10-05 | 13,700 | $1.78 | $24.4K | 31,458 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award deriv | 2015-02-25 | 2015-02-27 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award | 2015-02-25 | 2015-02-27 | 6,758 | — | $0 | 17,758 | SEC↗ |
| CPXX Celator Pharmaceuticals In | P Buy | 2014-11-18 | 2014-11-18 | 6,000 | $2.20 | $13.2K | 11,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | P Buy | 2014-05-15 | 2014-05-16 | 2,500 | $2.50 | $6.3K | 5,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award deriv | 2014-02-18 | 2014-02-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | P Buy | 2013-12-17 | 2013-12-17 | 2,500 | $3.50 | $8.8K | 2,500 | SEC↗ |
| NONE Celator Pharmaceuticals In | A Award deriv | 2013-06-03 | 2013-06-04 | 253,000 | — | $0 | 28,000 | SEC↗ |